Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
18 May 2020
18 May 2020
Historique:
entrez:
9
6
2020
pubmed:
9
6
2020
medline:
9
6
2020
Statut:
epublish
Résumé
The new coronavirus disease 2019 (COVID-19) has required the implementation of severe mobility restrictions and social distancing measures worldwide. While these measures have been proven effective in abating the epidemic in several countries, it is important to estimate the effectiveness of testing and tracing strategies to avoid a potential second wave of the COVID-19 epidemic. We integrate highly detailed (anonymized, privacy-enhanced) mobility data from mobile devices, with census and demographic data to build a detailed agent-based model to describe the transmission dynamics of SARS-CoV-2 in the Boston metropolitan area. We find that enforcing strict social distancing followed by a policy based on a robust level of testing, contact-tracing and household quarantine, could keep the disease at a level that does not exceed the capacity of the health care system. Assuming the identification of 50% of the symptomatic infections, and the tracing of 40% of their contacts and households, which corresponds to about 9% of individuals quarantined, the ensuing reduction in transmission allows the reopening of economic activities while attaining a manageable impact on the health care system. Our results show that a response system based on enhanced testing and contact tracing can play a major role in relaxing social distancing interventions in the absence of herd immunity against SARS-CoV-2.
Identifiants
pubmed: 32511536
doi: 10.1101/2020.05.06.20092841
pmc: PMC7273304
pii:
doi:
Types de publication
Preprint
Langues
eng
Commentaires et corrections
Type : UpdateIn
Références
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
PLoS Comput Biol. 2013;9(8):e1003169
pubmed: 23966843
Science. 2020 Jun 26;368(6498):1481-1486
pubmed: 32350060
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Sci Rep. 2019 Oct 22;9(1):15141
pubmed: 31641189
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
J Theor Biol. 2017 Apr 21;419:1-7
pubmed: 28161415
Science. 2020 May 1;368(6490):493-497
pubmed: 32213647
PLoS Med. 2008 Mar 25;5(3):e74
pubmed: 18366252
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12680-12685
pubmed: 30463945
Science. 2020 May 8;368(6491):
pubmed: 32234805
Lancet. 2020 Apr 25;395(10233):1382-1393
pubmed: 32277878
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Lancet Infect Dis. 2020 Jul;20(7):793-802
pubmed: 32247326
Science. 2020 Jul 24;369(6502):413-422
pubmed: 32532802
PLoS One. 2015 Jul 15;10(7):e0133203
pubmed: 26176549